Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie Germany-Decker"'
Autor:
Karen Qualls-Goodwin, Bonnie J. Bowdon, William M. Shannon, Julie Germany-Decker, Robert W. Buckheit
Publikováno v:
Proceedings of the National Academy of Sciences. 89:8361-8365
A cocultivation assay system consisting of uninfected human T cells and cells chronically infected with human immunodeficiency virus type 1 has been used to investigate syncytium formation in short-term assays. Continuous treatment or short-term pret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae27a018fe0cc3535ea19d988584b422
https://doi.org/10.1073/pnas.89.17.8361
https://doi.org/10.1073/pnas.89.17.8361
Autor:
Robert W. Buckheit, Lois B. Allen, William M. Shannon, Melinda G. Hollingshead, Paul A. J. Janssen, Julie Germany-Decker, Michael A. Chirigos
Publikováno v:
AIDS research and human retroviruses. 9(11)
R82913 and R86183, two derivatives of tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione (TIBO), were found to potently and selectively inhibit the replication and cell killing effects of a panel of biologically diverse laboratory and clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df51084a10fa782a385beed2e1cc31d
https://pubmed.ncbi.nlm.nih.gov/7508723
https://pubmed.ncbi.nlm.nih.gov/7508723
Autor:
Julie Germany-Decker, Michael R. Boyd, W. Don Decker, John P. Bader, Larry J. Ross, James B. McMahon, E. Lucile White, Melinda G. Hollingshead, Lois B. Allen, Louise Westbrook, Owen S. Weislow, William M. Shannon, Robert W. Buckheit
Publikováno v:
Antiviral research. 21(3)
Thiazolobenzimidazole (NSC 625487) was a highly potent inhibitor of human immunodeficiency virus-induced cell killing and viral replication in a variety of human cell lines, as well as fresh human peripheral blood lymphocytes and macrophages. The com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b99adc0c64fab6a6dd14928353b713
https://pubmed.ncbi.nlm.nih.gov/7692815
https://pubmed.ncbi.nlm.nih.gov/7692815
Autor:
Louise Westbrook, John C. Drach, Robert Chen, Robert W. Buckheit, E. Lucile White, Louis S. Kucera, Leroy B. Townsend, M. Reza Nassiri, Barbara R. Toyer, William M. Shannon, Shelby H. Puckett, Nathan P. Iyer, Charles Shipman, Julie Germany-Decker
Publikováno v:
AIDS research and human retroviruses. 9(4)
Triciribine (TCN) and its 5'-monophosphate (TCN-P) are novel tricyclic compounds with known antitumor activity; TCN-P is currently in phase II human clinical trials. We now report that these compounds have potent and selective activity against HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cddf3846bab2e61da646b032b1392e4
https://pubmed.ncbi.nlm.nih.gov/7685612
https://pubmed.ncbi.nlm.nih.gov/7685612